Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype
Open Access
- 1 September 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 13 (9) , 1063-1068
Abstract
Background. A North American genome-wide single nucleotide polymorphism (SNP) association study identified IL23R as a novel inflammatory bowel disease (IBD) susKeywords
This publication has 33 references indexed in Scilit:
- A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1Nature Genetics, 2006
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationJournal of Experimental Medicine, 2006
- IL-23 plays a key role inHelicobacter hepaticus–induced T cell–dependent colitisJournal of Experimental Medicine, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- Phenotype-Stratified Genetic Linkage Study Demonstrates that IBD2 Is an Extensive Ulcerative Colitis LocusAmerican Journal of Gastroenterology, 2006
- ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approachHuman Molecular Genetics, 2006
- Understanding the IL-23–IL-17 immune pathwayTrends in Immunology, 2006
- A haplotype map of the human genomeNature, 2005
- IBD5 is a General Risk Factor for Inflammatory Bowel Disease: Replication of Association with Crohn Disease and Identification of a Novel Association with Ulcerative ColitisThe American Journal of Human Genetics, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003